Our Services
Artis BioSolutions combines synthetic DNA manufacturing, process and analytical development, and GMP manufacturing within a single integrated platform spanning the US and EU, supporting advanced therapy programs from starting material through clinical manufacturing.
An Integrated Platform Built for Advanced Therapies
Synthetic DNA Manufacturing
GMP-ready and RUO cell-free synthetic DNA produced enzymatically without plasmid dependency
Process and Formulation Development
Process and formulation development designed for scalability and GMP readiness
Analytical Development
Analytical development, characterization, potency testing, and quality control
GMP Manufacturing
Modular GMP manufacturing and fill & finish capabilities supporting clinical supply
CMC Strategy
Integrated CMC planning and regulatory support aligned with development and manufacturing
Designed to De-Risk, Accelerate, and Scale, All in House
Reduce technical & regulatory risk
Minimize external handoffs
Maintain process & data continuity
Accelerate transfer into GMP manufacturing
Scale efficiently while preserving product quality
Flexible Engagement Models
Artis offers flexible partnership models, from co-development and platform-based execution to full process transfer and GMP manufacturing, allowing clients to engage in the way that best fits their program needs.